Apollomics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- August 29, 2016
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $9,750,000
Company Info
- Company Description
- Apollomics is a biopharmaceutical company discovering and developing mono- and combination- oncology therapies to harness the immune system.
- Market
- Oncology
- Location
- Foster City, California, USA
- Coinvestors
- OrbiMed Asia